Showing results (21-30 of 104) with videos related to
Sort By:
Pageof 11
Expert Review of Neurotherapeutics|October 9, 2009
Treatment of myasthenia gravis: current practice and future directionsEmma Ciafaloni, Donald B SandersAutoimmunity|February 20, 2010
Immunosuppressive therapies in myasthenia gravisDonald B Sanders, Amelia EvoliMuscle & Nerve|July 18, 2009
Acetylcholine receptor-alpha subunit expression in myasthenia gravis: a role for the autoantigen in pathogenesis?Jian Rong Sheng, Liang Cheng Li, Bellur S Prabhakar, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 15, 2021
If Thymectomy Reduces the Risk of Progression of Ocular to Generalized Myasthenia Gravis, Who Should Receive it?Gary R Cutter, Donald B SandersMuscle & Nerve|August 26, 2009
Jitter recordings with concentric needle electrodesErik V Stålberg, Donald B SandersJournal of Neuroimmunology|August 8, 2008
MuSK-antibody positive myasthenia gravis: questions from the clinicDonald B Sanders, Vern C JuelCurrent Opinion in Neurology|July 9, 2010
Update on muscle-specific tyrosine kinase antibody positive myasthenia gravisJeffrey T Guptill, Donald B SandersJournal of Autoimmunity|January 7, 2014
Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune myasthenia gravisMuthusamy Thiruppathi, Jian Rong Sheng, Liangcheng Li, et al.Journal of Clinical Neuromuscular Disease|December 17, 2008
On the concept of myasthenic crisisRichard S Bedlack, Donald B SandersAnnals of the New York Academy of Sciences|June 24, 2008
Lessons from two trials of mycophenolate mofetil in myasthenia gravisDonald B Sanders, Zaeem A SiddiqiPageof 11